The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction: The ECTIM Study
Abstract
Background Polymorphisms of the β fibrinogen gene have been shown to affect plasma fibrinogen levels and the risk of peripheral arterial disease. We now present the results of a detailed analysis of the β fibrinogen gene in relation to plasma fibrinogen and to the severity of coronary artery disease (CAD) in patients with myocardial infarction (MI) in the ECTIM Study. Methods and Results Ten polymorphisms of the β fibrinogen gene, including five new polymorphisms identified by single-strand conformation polymorphism analysis, and one polymorphism in the 3′ flanking region of the α fibrinogen gene were investigated in 565 patients with MI and 668 control subjects. The polymorphisms were in tight linkage disequilibrium and the genotype frequencies were similar in patients with MI and control subjects. In the multivariate analysis, only two polymorphisms, β Hae III ( P <.0003) and β-854 ( P <.01), were independently associated with plasma fibrinogen. The significant association between β fibrinogen polymorphisms and plasma fibrinogen was present in smokers but not in nonsmokers. In French MI patients, the number of coronary arteries with >50% stenosis was estimated by angiography and used as a criterion for severity of CAD. Presence of the less frequent allele of the β Bcl I ( P <.0003) and of other polymorphisms was positively associated with the severity of CAD. Conclusions Genetic variants of the β fibrinogen gene are associated with an increased plasma level of fibrinogen, especially in smokers. The association with CAD appears to be the consequence of an increased risk of MI in subjects with severe CAD who carry the predisposing β fibrinogen genotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Molecular Evolutionary Genetics
Nei, M. (1987) · Columbia University Press eBooks · doi:10.7312/nei-92038 · Cited by 15,271
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., & Sekiya, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2766 · Cited by 3,610
Meade, T. W., Brozovic, M., Chakrabarti, R. R., Haines, A. P., Imeson, J. D., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,939
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Saiki, R. K., Bugawan, T. L., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1986) · Nature · doi:10.1038/324163a0 · Cited by 1,827
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,646
Yarnell, J. W., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., Whitehead, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 916
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
Cited by
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
Rosenson, R. S., & Tangney, C. C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 954
Zhang, B., Ye, S., Herrmann, S.-M., Eriksson, P., de Maat, M., Evans, A., Arveiler, D., Luc, G., Cambien, F., Hamsten, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.14.1788 · Cited by 611
Self-citationRole of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
Obesity, haemostasis and the fibrinolytic system
Mertens, I., & Gaal, L. F. V. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00056.x · Cited by 368
Metadata
- Authors
- Behague, I., Poirier, O., Nicaud, V., Evans, A., Arveiler, D., Luc, G., Cambou, J.-P., Scarabin, P.-Y., Bara, L., Green, F., & Cambien, F.
- Venue
- Circulation
- Published
- 1996-02
- Volume
- 93
- Issue
- 3
- Pages
- 440-449
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1975015154
- Cited by
- 282
- References
- 36
- FWCI
- 25.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction: The ECTIM Study. https://app.cochat.ai/papers/10.1161/01.cir.93.3.440
- The paper
- Behague, I., Poirier, O., Nicaud, V., Evans, A., Arveiler, D., Luc, G., Cambou, J.-P., Scarabin, P.-Y., Bara, L., Green, F., & Cambien, F. (1996). β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction: The ECTIM Study. Circulation. https://doi.org/10.1161/01.cir.93.3.440
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.